2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | CN¥29B | CN¥31B | CN¥28B | CN¥28B | CN¥28B |
Cost of Revenue | CN¥20B | CN¥22B | CN¥20B | CN¥18B | CN¥16B |
Gross Profit | CN¥9.3B | CN¥9.4B | CN¥8.8B | CN¥9.8B | CN¥12B |
Gross Profit % | 32% | 30% | 31% | 35% | 42% |
R&D Expenses | CN¥1.7B | CN¥2.3B | CN¥2.6B | CN¥0 | CN¥0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | CN¥4.6B | CN¥3.6B | CN¥4.4B | CN¥6B | CN¥6.6B |
Dep. & Amort. | CN¥824M | CN¥1B | CN¥1.2B | CN¥1B | CN¥0 |
Def. Tax | -CN¥64M | -CN¥196M | CN¥0 | CN¥0 | CN¥0 |
Stock Comp. | CN¥569M | CN¥647M | CN¥665M | CN¥670M | CN¥681M |
Chg. in WC | -CN¥497M | CN¥573M | CN¥2.2B | CN¥786M | CN¥0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | CN¥11B | CN¥6.6B | CN¥9.6B | CN¥14B | CN¥13B |
ST Investments | CN¥15B | CN¥14B | CN¥11B | CN¥10B | CN¥14B |
Cash & ST Inv. | CN¥26B | CN¥20B | CN¥21B | CN¥24B | CN¥27B |
Receivables | CN¥2.8B | CN¥3.6B | CN¥2.7B | CN¥2.9B | CN¥3.5B |
Inventory | CN¥18M | CN¥24M | CN¥14M | CN¥8M | CN¥23M |
TME achieved significant financial growth in 2024, with total revenues increasing by 8% year-over-year in Q4 to RMB 7.5 billion, driven by a 16% growth in online music revenues and an 18% rise in music subscription revenues.
The company announced a new $1 billion share repurchase program over the next 24 months and an annual dividend of $273 million, reflecting confidence in future growth.
TME's subscriber base grew to 121 million, a 13% year-over-year increase, with ARPPU also showing steady growth. The SVIP membership program contributed significantly to revenue and user engagement.
The company plans to focus on AI-driven innovations, content ecosystem expansion, and international markets in 2025, aiming for accelerated revenue growth and improved margins.
TME observed strong demand for live concerts and artist merchandise, with plans to organize high-quality live performances and further integrate AI technologies to enhance user experiences and operational efficiency.